Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06467357
Title Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer (DESTINY-BTC01)
Acronym DESTINY-BTC01
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | DEU | CAN | BEL | AUT

Facility Status City State Zip Country Details
Research Site Linz 4010 Austria Details
Research Site Salzburg 5020 Austria Details
Research Site Wiener Neustadt 2700 Austria Details
Research Site Wien 1090 Austria Details
Research Site Anderlecht 1070 Belgium Details
Research Site Edegem 2650 Belgium Details
Research Site Leuven 3000 Belgium Details
Research Site Liège 4000 Belgium Details
Research Site Roeselare 8800 Belgium Details
Research Site Porto Alegre 90035-000 Brazil Details
Research Site Sao Paulo 01246-000 Brazil Details
Research Site Halifax Nova Scotia B3H 1V7 Canada Details
Research Site Toronto Ontario M5G 2M9 Canada Details
Research Site Montreal Quebec H3A 1A1 Canada Details
Research Site Berlin 13353 Germany Details
Research Site Dresden 01370 Germany Details
Research Site Frankfurt 60488 Germany Details
Research Site Göttingen 37075 Germany Details
Research Site Hamburg 22763 Germany Details
Research Site Köln 50937 Germany Details
Research Site Leipzig 4103 Germany Details
Research Site Lübeck 23538 Germany Details
Research Site Munchen 81377, DE Germany Details
Research Site Ulm 89081 Germany Details
Research Site Wuerzburg 97080 Germany Details
Research Site Kashiwa 227-8577 Japan Details
Research Site Koto-ku 135-8550 Japan Details
Research Site Osaka-shi 541-8567 Japan Details
Research Site Suita-city 565-0871 Japan Details
Research Site Yokohama-shi 241-8515 Japan Details
Research Site Seoul 03080 Korea, Republic of Details
Research Site Rotterdam 3015 GD Netherlands Details
Research Site Kaohsiung 833 Taiwan Details
Research Site Taipei 10002 Taiwan Details
Research Site Taipei 112 Taiwan Details
Research Site Taoyuan 333 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field